Amgen Launches AMGEVITA™ (Biosimilar Adalimumab) In Markets Across Europe
Go back to Amgen Launches AMGEVITA™ (Biosimilar Adalimumab) In Markets Across Europe| Amgen Inc (NASDAQ: AMGN) | Delayed: 442.84 +4.72 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $438.12 | 52 Week High | $176.85 | |||
| Open | $440.65 | 52 Week Low | $133.64 | |||
| Day High | $445.57 | P/E | 66.69 | |||
| Day Low | $435.00 | EPS | $6.64 | |||
| Volume | 2,285,556 | |||||

